Assessment of Bone Density Following Application of BMAC Around Zygomatic Implant
ConditionSevere Maxillary Atrophy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCairo University
About this trial
This prospective case series is designed to evaluate the effect of autologous bone marrow aspirate concentrate applied around zygomatic implants placed via the intrasinus approach. The study will include adult patients with severe maxillary atrophy requiring zygomatic implant rehabilitation. BMAC will be prepared from iliac crest aspirate and loaded on gelatin sponge at the implant site. Peri-implant bone density will be assessed using CBCT at baseline and 6 months postoperatively. Secondary implant stability will be measured using resonance frequency analysis. (Recruitment has not started yet)
Eligibility criteria
Qualifiers
Patients over 18 years old.
Patients requiring rehabilitation with zygomatic implants in the posterior maxilla.
Patients who are willing to participate and able to provide informed consent.
Disqualifiers
Pregnant women.
Individuals with history of radiation therapy or other contraindications for surgery.
Patients with bone marrow diseases.
Patients with local infections at intraoral surgical site or bone marrow aspiration site.
Trial design
Treatments tested in this trial
- zygomatic implants placement
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov